Failure to Start: Filling the cracks COVID exposed in patient onboarding support to enable successful new therapy initiations in an uncertain world
Andrea Heslin-Smiley, President and CEO, VMS BioMarketing
Tim Aungst, PharmD, Associate Professor of Pharmacy Practice at MCPHS University, writer of The Digital Apothecary blog
Kristy Donnelly, Patient Advocate–Crohn's Disease, KristyJ YouTube Channel
Joe Reynolds, Sr. Manager, Strategy & Patient Insights, Noble
Erika Bajars, Principal and Founder, Matchstick (Moderator)
COVID social distancing policies revealed cracks in our support system for training and onboarding patients onto biologic therapies. Heavy reliance on HCPs and in-person training support failed patients during the pandemic. As a result, many patients hoping to start therapy delayed relief, and recent starts were asked to slow down their loading doses. Access to training support and medication management disappeared for many who moved forward initiating new treatments. Physical training tools collect dust in drawers in empty clinics, and HCPs and patients lack broad awareness of and accessibility to tools appropriate for remote onboarding.
Reasons to attend
This dynamic one-hour virtual panel provides you with four different perspectives regarding the “cracks” in the system, presents alternative patient support models already in use, and considers the possibilities of what onboarding support might look like moving forward. You’ll get to interact with the speakers and join a working group to continue the discussion if you’re interested.
About the Sponsors
Noble, an Aptar Company, has an unwavering commitment to helping patients initiate and stay on therapies to treat chronic disease by providing support tools for HCPs and patients. They develop training devices for the industry's leading manufacturers of autoinjectors, prefilled syringes, on-body injectors, and respiratory devices.
Noble is part of Aptar Pharma, a global leader in drug delivery systems, services and active packaging solutions, across a wide range of delivery routes.For more information please visit www.gonoble.com/.